← Evidence map

ReviewCurrent opinion in pulmonary medicine2025

Challenges and opportunities for drug development in rare pulmonary diseases like cystic fibrosis: an industry perspective.

Zachary M Sellers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40916973